Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pyoderma gangrenosum-acne-suppurative hidradenitis syndrome.
10 publications have been identified in PubMed for pyoderma gangrenosum-acne-suppurative hidradenitis syndrome. Research spans Case Report / Case Series (78%) and Review / Meta-Analysis (22%).
Javaheri E (2026). [PMID: 42027857](https://pubmed.ncbi.nlm.nih.gov/42027857/). *JAAD Case Rep*. [Case Report / Case Series]
Mallela T (2025). [PMID: 40542230](https://pubmed.ncbi.nlm.nih.gov/40542230/). *Dermatology and therapy*. [Review / Meta-Analysis]
Velasco-Amador JP (2025). [PMID: 39814648](https://pubmed.ncbi.nlm.nih.gov/39814648/). *Medicina clinica*. [Case Report / Case Series]
Qin Q (2025). [PMID: 40861239](https://pubmed.ncbi.nlm.nih.gov/40861239/). *Frontiers in medicine*. [Case Report / Case Series]
Feola H (2025). [PMID: 38880986](https://pubmed.ncbi.nlm.nih.gov/38880986/). *International journal of dermatology*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:22 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Abdul Rahman N (2024). [PMID: 39359769](https://pubmed.ncbi.nlm.nih.gov/39359769/). *Annals of medicine and surgery (2012)*. [Case Report / Case Series]
Yan A (2024). [PMID: 38878169](https://pubmed.ncbi.nlm.nih.gov/38878169/). *Archives of dermatological research*. [Case Report / Case Series]
Ahmad A (2024). [PMID: 39006661](https://pubmed.ncbi.nlm.nih.gov/39006661/). *Cureus*. [Case Report / Case Series]
Metko D (2024). [PMID: 39560772](https://pubmed.ncbi.nlm.nih.gov/39560772/). *Archives of dermatological research*. [Review / Meta-Analysis]
AI-curated news mentioning pyoderma gangrenosum-acne-suppurative hidradenitis syndrome
Updated Sep 16, 2026
A recent study published in PubMed explores atypical visceral involvement in pyoderma gangrenosum, shedding light on its broader implications. This research may enhance understanding of the disease's systemic effects.
A recent study highlights the use of guselkumab as an effective adjunct treatment for pyoderma gangrenosum, while successfully maintaining clinical remission in patients with ulcerative colitis. This finding could influence treatment strategies for patients suffering from these conditions.
A new classification system for pyoderma gangrenosum phenotypes has been proposed, enhancing understanding of this rare skin condition. This research aims to improve diagnosis and treatment strategies for affected patients.